Περίληψη:
Study Objectives: Patients with chronic kidney disease (CKD) often report poor sleep quality, but they commonly exhibit OSA. The aim of this study was to evaluate the influence of OSA severity and of estimated glomerular filtration rate impairment on objective sleep quality in nondialyzed patients with CKD, defined as an estimated glomerular filtration rate <60 mL/min/1.73m2. Methods: Polysomnographic sleep characteristics were compared between patients with (n = 430) and without CKD (n = 6,639) in the European Sleep Apnea Database cohort. Comparisons were repeated in 375 patients with CKD and 375 control patients without CKD matched for sleep center, age, sex, and AHI, and in 310 matched CKD and non-CKD patients without psychiatric disturbances. Results: Among all patients with and without CKD, total sleep time was similar but sleep stage N1 (median 8.7% [IQR 4.8-18.0] vs 6.7% [3.6-12.7], respectively) and sleep stage R (12.6% [6.8-17.7] vs 14.2% [8.8-19.8], respectively) significantly differed (P <.0001). No difference in sleep characteristics was observed between matched patients either with or without psychiatric disturbances. After subdividing the matched patients according to AHI tertile (<25, ≥25 to <49, and ≥49 events/h) and estimated glomerular filtration rate (≥60, 45 to <60, <45 mL/min/1.73m2), we found a significant effect of AHI on sleep stages N2, N3, and R (P <.001), but there was no effect of CKD. Conclusions: In nondialyzed patients with CKD, objective sleep quality is influenced similarly by AHI as in patients without CKD but is not affected by CKD severity. Previously reported poor sleep quality in CKD may partly result from the high prevalence of OSA in CKD. © 2020 American Academy of Sleep Medicine. All rights reserved.
Συγγραφείς:
Marrone, O.
Cibella, F.
Roisman, G.
Sliwinski, P.
Joppa, P.
Basoglu, O.K.
Bouloukaki, I.
Schiza, S.
Pataka, A.
Staats, R.
Verbraecken, J.
Hedner, J.
Grote, L.
Bonsignore, M.R.
Anttalainen, U.
Saaresranta, T.
Bailly, S.
Pépin, J.-L.
Tamisier, R.
Basoglu, O.K.
Tasbakan, S.
Bonsignore, M.R.
Cibella, F.
Bouloukaki, I.
Schiza, S.
Dogas, Z.
Drummond, M.
von Zeller, M.
Escourrou, P.
Roisman, G.
Fietze, I.
Penzel, T.
Grote, L.
Hedner, J.
Zou, D.
Gouveris, H.
Joppa, P.
Tkacova, R.
Hein, H.
Kent, B.D.
McNicholas, W.T.
Ryan, S.
Kvamme, J.A.
Lombardi, C.
Parati, G.
Ludka, O.
Mihaicuta, S.
Pataka, A.
Plywaczewski, R.
Sliwinski, P.
Pretl, M.
Riha, R.
Staats, R.
Steiropoulos, P.
Trakada, G.
Verbraecken, J.
ESADA study group
Λέξεις-κλειδιά:
central stimulant agent; creatinine, adult; age; aged; Article; chronic kidney failure; cohort analysis; controlled clinical trial; controlled study; creatinine blood level; disease severity; estimated glomerular filtration rate; female; human; kidney dysfunction; major clinical study; male; mental disease; multicenter study; polysomnography; population based case control study; prospective study; sex; sleep disordered breathing; sleep quality; sleep stage; sleep time; very elderly; chronic kidney failure; complication; kidney; sleep; sleep disordered breathing, Humans; Kidney; Renal Insufficiency, Chronic; Sleep; Sleep Apnea Syndromes; Sleep Apnea, Obstructive
